P1.06B.16 HER3 Expression Across Genomic Subsets of NSCLC von Gupta, B., Baca, Y., Hubbard, G., Reuss, J.E., Lau, S.C.M., Elliott, A., Garassino, M.C., Vanderwalde, A.M., Ma, P.C., Halmos, B., Liu, S.V.

Volltext

EP08.01-067 Rechallenging with PD-1 Inhibitors: Incidence and Management of Immune-Related Adverse Events in Metastatic NSCLC von Hoang, T., Elliot, M.J., Poletes, C., Makarem, M., Corke, L., Weiss, J., Tsao, M.-S., Bradbury, P., Shepherd, F.A., Liu, G., Leighl, N., Sacher, A., Lau, S.C.M.

Volltext

P2.04-03 EGRET: First-in-human Study of the Novel Antibody-drug Conjugate AZD9592 ± Anti-cancer Agents in Advanced Solid Tumours von Aggarwal, C., Solomon, B., Spira, A., Massarelli, E., Lau, S.C.m., Le, X., Rolfo, C., Planchard, D., Felip, E., Wu, Y.-L., Ahn, M.-J., Goto, K., Azaro, A., Lissa, D., Hamid, O., McGrath, L., Maudsley, R., Hayward, C., Mathewson, A., Arnaldez, F., Grenga, I., Azzoli, C.

Volltext

Protective skin care behaviors in cancer survivors von Lau, S C M, Chen, L, Cheung, W Y

Volltext

1238TiP Combining immunotherapy with Trop2 ADc in early stage non-small cell lung cancer (CITADEL) von Li, S.C.M., Mok, T.S.K., Ng, C., Cheung, A.H., Chan, S., Lee, V.W.K., Lim, M.Y.F., Chow, J.C-H., Cheung, K.M., Li, K., Liao, G., Wong, I.W.C., Lee, V.H.F., Mok, S.T.F., Mok, K., Lau, R., Chan, J.W.Y., Nyaw, S.F.

Volltext

312P ClinMatch: A clinical trial matching platform that improves trial accessibility among NSCLC patients through comprehensive genomic and clinical profiling von Yu, A.C.S., Yim, A.K-Y., Nyaw, S.F., Li, K.K-M., Lau, Y.M., Li, S.C.M., Mok, S.T.F., Tang, G., Chang, A., Prêtre, V., Jin, N., Kai, A.K.L., Kan, T.C.M., Lee, H.C., Chan, T.F., Wong, C.S-C., Cho, W.C.S., Loong, H.H.F.

Volltext